Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of a Carbopol® 940 Hydrogel Functionalized With Plasma-Activated Water (PAW) in the Treatment of Chronic Wounds: A Randomized Controlled Trial

NCT07541196 is registered in ClinicalTrials.gov with Benjamín Gonzalo Rodríguez Méndez as lead sponsor.

NCT NCT07541196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07541196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of a Carbopol® 940 Hydrogel Functionalized With Plasma-Activated Water (PAW) in the Treatment of Chronic Wounds: A Randomized Controlled Trial
Lead sponsor
Benjamín Gonzalo Rodríguez Méndez
Phase
Not applicable
Overall status
Recruiting
Start date
April 20, 2026
Completion date
July 30, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial ulcer, chronic wound, diabetic foot ulcer (dfu), pressure ulcer (pu), venous leg ulcer, wound dehiscence